{"id":963530,"date":"2026-05-15T10:22:40","date_gmt":"2026-05-15T14:22:40","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\/"},"modified":"2026-05-15T10:22:40","modified_gmt":"2026-05-15T14:22:40","slug":"jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\/","title":{"rendered":"Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025"},"content":{"rendered":"
\n

New Taipei City, Taiwan, May 15, 2026 (GLOBE NEWSWIRE) — Jyong Biotech Ltd. (Nasdaq: MENS) (the \u201cCompany\u201d or \u201cJyong Biotech\u201d), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission (“SEC”) on May 14, 2026.<\/p>\n

The annual report can be accessed on the Company’s investor relations website at\u00a0https:\/\/jyongir.com\/<\/a>\u00a0as well as the SEC’s website at\u00a0http:\/\/www.sec.gov<\/a>.\u00a0<\/p>\n

The Company will provide a hard copy of annual report containing the audited consolidated financial statements, free of charge, to its shareholders upon request.\u00a0Requests should be directed to the Company at\u00a0ir@jyongbio.com<\/a> .\u00a0<\/p>\n

\n About Jyong Biotech Ltd.<\/b>\n <\/p>\n

Headquartered in Taiwan, Jyong Biotech Ltd. is a science-driven biotechnology company committed to developing and commercializing innovative and differentiated new drugs (plant-derived), mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia. Since its inception in 2002, the Company has built integrated capabilities that encompass all key functionalities of drug development, including early-stage drug discovery and development, pharmacology, toxicology, clinical trials, regulatory affairs, manufacturing, and commercialization. Leveraging strong research and development capabilities and a proprietary platform, the Company has been developing a series of botanical drug candidates, including its primary botanical drug candidate, BOTRESO\u00ae<\/sup>, another clinical-stage botanical drug candidate, and other preclinical-stage botanical drug candidates. The Company endeavors to develop and supply first-class innovative drugs to meet customers\u2019 health needs and seeks to be a valuable business organization that is held in high esteem by the public.<\/p>\n

For more information, please visit:\u00a0https:\/\/www.jyongbio.com\/<\/a>,\u00a0https:\/\/jyongir.com\/<\/a>.<\/p>\n

\n Forward-Looking Statement<\/b>\n <\/p>\n

This press release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as \u201cmay, \u201cwill, \u201cintend,\u201d \u201cshould,\u201d \u201cbelieve,\u201d \u201cexpect,\u201d \u201canticipate,\u201d \u201cproject,\u201d \u201cestimate\u201d or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and other factors discussed in the \u201cRisk Factors\u201d section of the registration statement, prospectuses, annual and interim reports, and other filings with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at\u00a0www.sec.gov<\/a>. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.<\/p>\n

\n For more information, please contact:<\/b>
\n
Jyong Biotech Ltd.
ir@jyongbio.com<\/a><\/p>\n

Investor Relations
WFS Investor Relations Inc.
Email:\u00a0services@wfsir.com<\/a>
Phone: +1 628 283 9214<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

New Taipei City, Taiwan, May 15, 2026 (GLOBE NEWSWIRE) — Jyong Biotech Ltd. (Nasdaq: MENS) (the \u201cCompany\u201d or \u201cJyong Biotech\u201d), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission (“SEC”) on May 14, 2026. The annual report can be accessed on the Company’s investor relations website at\u00a0https:\/\/jyongir.com\/\u00a0as well as the SEC’s website at\u00a0http:\/\/www.sec.gov.\u00a0 The Company will provide a hard copy of annual report containing the audited consolidated financial statements, free of charge, to its shareholders upon request.\u00a0Requests should be directed to the Company at\u00a0ir@jyongbio.com .\u00a0 About Jyong Biotech Ltd. … <\/p>\n

Continue reading “Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-963530","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nJyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"New Taipei City, Taiwan, May 15, 2026 (GLOBE NEWSWIRE) — Jyong Biotech Ltd. (Nasdaq: MENS) (the \u201cCompany\u201d or \u201cJyong Biotech\u201d), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission (“SEC”) on May 14, 2026. The annual report can be accessed on the Company’s investor relations website at\u00a0https:\/\/jyongir.com\/\u00a0as well as the SEC’s website at\u00a0http:\/\/www.sec.gov.\u00a0 The Company will provide a hard copy of annual report containing the audited consolidated financial statements, free of charge, to its shareholders upon request.\u00a0Requests should be directed to the Company at\u00a0ir@jyongbio.com .\u00a0 About Jyong Biotech Ltd. … Continue reading "Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-15T14:22:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMTIwMCM3NjA1ODU3IzUwMDE0ODIxMg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025\",\"datePublished\":\"2026-05-15T14:22:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\\\/\"},\"wordCount\":525,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyMTIwMCM3NjA1ODU3IzUwMDE0ODIxMg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\\\/\",\"name\":\"Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyMTIwMCM3NjA1ODU3IzUwMDE0ODIxMg==\",\"datePublished\":\"2026-05-15T14:22:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyMTIwMCM3NjA1ODU3IzUwMDE0ODIxMg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyMTIwMCM3NjA1ODU3IzUwMDE0ODIxMg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\/","og_locale":"en_US","og_type":"article","og_title":"Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025 - Market Newsdesk","og_description":"New Taipei City, Taiwan, May 15, 2026 (GLOBE NEWSWIRE) — Jyong Biotech Ltd. (Nasdaq: MENS) (the \u201cCompany\u201d or \u201cJyong Biotech\u201d), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission (“SEC”) on May 14, 2026. The annual report can be accessed on the Company’s investor relations website at\u00a0https:\/\/jyongir.com\/\u00a0as well as the SEC’s website at\u00a0http:\/\/www.sec.gov.\u00a0 The Company will provide a hard copy of annual report containing the audited consolidated financial statements, free of charge, to its shareholders upon request.\u00a0Requests should be directed to the Company at\u00a0ir@jyongbio.com .\u00a0 About Jyong Biotech Ltd. … Continue reading \"Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-15T14:22:40+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMTIwMCM3NjA1ODU3IzUwMDE0ODIxMg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025","datePublished":"2026-05-15T14:22:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\/"},"wordCount":525,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMTIwMCM3NjA1ODU3IzUwMDE0ODIxMg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\/","name":"Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMTIwMCM3NjA1ODU3IzUwMDE0ODIxMg==","datePublished":"2026-05-15T14:22:40+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMTIwMCM3NjA1ODU3IzUwMDE0ODIxMg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMTIwMCM3NjA1ODU3IzUwMDE0ODIxMg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jyong-biotech-ltd-files-annual-report-on-form-20-f-for-fiscal-year-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/963530","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=963530"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/963530\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=963530"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=963530"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=963530"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}